Cryoport (CYRX) Cost of Revenue (2010 - 2026)

Cryoport (CYRX) has 17 years of Cost of Revenue data on file, last reported at $25.9 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $25.9 million, up 15.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.6 million (up 10.68% YoY), and the FY2025 annual result was $93.1 million, up 6.9% from the prior year.
• Cost of Revenue rose to $25.9 million in Q1 2026 per CYRX's latest filing, from $23.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $35.7 million in Q1 2023 and troughed at -$6.6 million in Q4 2023.
• A 5-year average of $25.5 million and a median of $24.1 million in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue plunged 119.35% in 2023, then jumped 432.95% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $34.1 million in 2022, then sank by 119.35% to -$6.6 million in 2023, then jumped by 432.95% to $22.0 million in 2024, then increased by 8.11% to $23.7 million in 2025, then climbed by 9.04% to $25.9 million in 2026.
• Business Quant data shows CYRX's Cost of Revenue at $25.9 million in Q1 2026, $23.7 million in Q4 2025, and $22.9 million in Q3 2025.